English | Español

Technology/Innovation
+ Technology/Innovation
Ruth de Jauregui | May 30, 2017

AstraZeneca announces top-line results in EXSCEL Phase IIIb/IV trial of Bydureon in diabetes patients
+ Regulatory
John Breslin | May 30, 2017

Collapse of health insurance merger to benefit consumers, U.S. prosecutor says
+ Technology/Innovation
Robert Hadley | May 29, 2017

Amgen says Repatha an improvement over standard statin treatment
+ Technology/Innovation
Robert Hadley | May 29, 2017

Dermabond Prineo Skin Closure System can save money, cut infection risks, Johnson & Johnson says
+ Technology/Innovation
Robert Hadley | May 29, 2017

Restricted diet may trigger cravings, NIH study says
+ Community
Charmaine Little | May 29, 2017

NHLBI program raises awareness of COPD
+ Technology/Innovation
Robert Hadley | May 28, 2017

NIH study sheds new light on retinal disorders
+ Community
Robert Hadley | May 28, 2017

Bronchodilators equal corticosteroids for COPD use, Novartis study claims 

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes